Koers Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.
Aandelen
603168
CNE100001TG0
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8,81 CNY | +8,10% | -6,18% | -34,30% |
Omzet 2021 | 627 mln. 86,63 mln. 81,19 mln. | Omzet 2022 | 550 mln. 75,91 mln. 71,15 mln. | Marktkapitalisatie | 3,4 mld. 469 mln. 440 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | 35 mln. 4,84 mln. 4,53 mln. | Nettowinst (verlies) 2022 | 45 mln. 6,22 mln. 5,83 mln. | EV/omzet 2021 | 4,55 x |
Nettoliquiditeiten 2021 | 206 mln. 28,45 mln. 26,66 mln. | Nettoliquiditeiten 2022 | 515 mln. 71,09 mln. 66,63 mln. | EV/omzet 2022 | 5,25 x |
K/w-verhouding 2021 |
86,2
x | K/w-verhouding 2022 |
65,7
x | Werknemers | 1.241 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
0,41% | Vrij verhandelbaar | 45,17% |
1 dag | +8,10% | ||
1 week | -6,18% | ||
Lopende maand | -12,86% | ||
1 maand | -11,90% | ||
3 maanden | -21,34% | ||
6 maanden | -42,64% | ||
Lopend jaar | -34,30% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Biao Yan
CEO | Chief Executive Officer | 42 | 28-08-20 |
Xiu Song Lin
DFI | Director of Finance/CFO | 55 | 17-12-20 |
Kai Lin
BRD | Director/Board Member | 30 | 19-05-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Guo Tong Xu
BRD | Director/Board Member | 67 | 28-08-20 |
Wei Min Wang
BRD | Director/Board Member | 73 | 02-04-10 |
Zheng Guo Hu
BRD | Director/Board Member | 58 | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
17-04-24 | 8,81 | +8,10% | 10 907 200 |
16-04-24 | 8,15 | -8,22% | 12 932 250 |
15-04-24 | 8,88 | -4,82% | 12 551 940 |
12-04-24 | 9,33 | +0,21% | 6 936 732 |
11-04-24 | 9,31 | -0,85% | 6 810 973 |
slotkoers Shanghai S.E., 17 april 2024
Meer koersenWinst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-34,30% | 461 mln. | |
+28,79% | 676 mld. | |
+24,82% | 554 mld. | |
-7,64% | 349 mld. | |
+15,00% | 318 mld. | |
+5,99% | 291 mld. | |
+3,30% | 210 mld. | |
-0,07% | 204 mld. | |
-9,65% | 194 mld. | |
-11,71% | 144 mld. |